TC Biopharm (Holdings) Plc (TCBP) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Operating IncomeNet Income
050K100K150K200K250K300K350K400KQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Margin (%)

Operating Expenses

Research And Development ExpensesSelling And Marketing ExpensesGeneral And Administrative Expenses
01M2M3M4M5M6M7M8MQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

EBITDA

EBITDA
-8M-7M-6M-5M-4M-3M-2M-1000K1Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

EPS

EPSEPS Diluted
000111222Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Revenue Variation (%)

Income Variation (%)

Operating Income VariationNet Income Variation
02581012151820Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Revenue YoY Variation (%)

Revenue YoY Variation
-200-175-150-125-100-74-49-241Q2 2023Q3 2023Q4 2023

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
062125188250312375438500Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Price-to-Earning Ratio

P/E Ratio
-1000100200300400500600700Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
01M2M3M4M6M7M8M9MQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Per Share Metrics

Net Income Per ShareOperating Cash Flow Per Share
000001111Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
05K10K15K20K25K30K35K40KQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Free Cash Flow

Cash At End Of Period
0250K500K750K1M1M2M2M2MQ1 2024Q2 2024

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
0625K1M2M2M3M4M4M5MQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024
🏦 Balance Sheet
📈 Key Metrics